YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Celgene Corp. signed on to purchase blood-disease biotechnology company Impact Biomedicines.
The deal is worth as much as $7 billion, subject to milestones related to regulatory obstacles and sales performance.
Celgene agreed to make a $1.1 billion upfront payment for the San Diego-based privately held company.
Read more from The Wall Street Journal.
A City Utilities employee since 2017 with a 25-year legal background, he now leads the municipal utility provider with an $895 million annual budget.
City employee dies in landfill accident
LORE names members, raises $430K
Kehoe appoints 3 locals to state boards, commission
Spring 2025 Architects & Engineers Project Report
Financial consulting, investment firm Ozarks Capital debuts
Letter to the Editor: These candidates embody unity, collaboration, independence
Council postpones vote on tax payment requirement for occupational licenses